MedTrace Logo

Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.

NCT00124059 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2015-10-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether seroquel is effective in the treatment of type A and type B alcohol dependence.

Conditions

  • Alcoholism

Interventions

DRUG

Seroquel

400mg/day quetiapine

DRUG

Placebo

400mg/day placebo

Sponsors & Collaborators

Principal Investigators

  • Helen M Pettinati, PhD · University of Pennsylvania Treatment Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2005-09-30
Completion
2005-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00124059 on ClinicalTrials.gov